1. Specimen Verification Requirements
Basics of Transfusion Science
Definition: Transfusion science is a branch of medicine focused on the safe and effective use of blood and blood components for patient care.
Also referred to as:
Blood Bank (BB)
Immunohematology
Transfusion Medicine (TM)
Transfusion Services
Key areas included in transfusion science:
Blood typing – ABO/Rh
Compatibility testing – transfusion of blood
Blood donations including testing for Transfusion-Transmissible Infections (TTI), component preparation, product storage
Management of transfusion reactions
Specimen Collection and Testing Requirements
Preferred Specimen: K2 EDTA
Both red cells and plasma/serum tested.
RBCs exhibit antigens on their membrane surface; plasma/serum contains antibodies.
**Specimen Handling: **
Serum can be used, red stoppered tubes acceptable.
Critical pre-analytical procedures must be followed to prevent errors.
Labeling and Traceability Protocols for Transfusion Specimens
Pre-analytical Procedures
The most dangerous pre-analytical error: wrong blood in tube.
Mandatory that patients are positively identified using at least two unique identifiers:
Full name
Unique hospital number
Date of birth (D.O.B.)
Patients should be asked to confirm their full name and D.O.B. when possible.
Specimen Labeling:
Must label specimens immediately at the bedside – pre-labeling is not allowed.
Labels applied before leaving the patient.
Unlabeled or mislabeled specimens must be rejected (no exceptions).
Preferred barcode labels must contain:
Patient’s full name
Unique ID number
D.O.B.
Date and time of collection
Phlebotomist initials or ID
Physician (optional)
Specimen Collection Considerations
Specimen must match strict criteria:
Request form must match specimen label must match patient wristband.
Document the phlebotomist who collected or tested samples for traceability.
Testing should occur within a 72-hour window to avoid missing complement dependent antibodies.
Traceability of Specimens
Definition of Traceability: Ability to track the specimen from its collection through to its final disposition.
Coverage of Traceability Must Include:
Patient → specimen → testing → blood component → transfusion outcome.
Traceability Document Requirements include:
Collection record
Transport log
Laboratory accession number
Testing worksheets or Laboratory Information System (LIS) records
Blood products transfused (including unique donation number, component type, ABO/Rh type, expiry date)
Compatibility test results.
Transfusion record and monitoring data.
Blood Product Traceability
In case of a transfusion-related adverse outcome, records must allow positive matching of the product to the patient.
Every unit must be traceable:
Look-back or traceback allowed by Canadian Blood Services from donor to product transfused.
Trace from donor through processing, storage to recipient or disposal.
Specimen Rejection Criteria
Specimen must be rejected if:
Patient identifiers are missing or incorrect.
Label does not match the request form.
Sample collected in the wrong tube.
Specimen is hemolyzed or contaminated.
Specimen collected outside the allowed time window (e.g. >72 hours for recently transfused patients).
Retention and Record Keeping
Specimens
Stored per policy, often for 7 days post-transfusion.
Blood Bank Records
Kept for 10 to 30 years depending on local regulations.
All records must be:
Legible
Secure
Auditable
Transfusion Records
Must retain records of release of blood components and products for transfusion including:
Recipient identification
Donation codes
Lot numbers of products for a minimum of 50 years.
Verification of Information and Sample Suitability
Before specimen acceptance:
Ensure all relevant info for testing requested is complete, accurate, and legible.
Relevant verification information includes:
Patient’s full name
Unique patient identification number
Date of birth (DOB)
Test(s) requested
Date and time of specimen collection
Phlebotomist or collector identification.
Assessing Specimen Suitability
Any discrepancy between specimen label and request form makes the sample unsuitable.
Confirm appropriate anticoagulant and specimen type.
Evaluate specimen volume and visual inspect for hemolysis or clotting (especially in EDTA samples).
Assess specimen age and stability, taking into consideration recent transfusions or pregnancies.
Document acceptance or rejection and determine course of action for preanalytical errors.
Follow established transfusion science protocols focused on patient safety and documentation.
Blood Bank Specific Checks
Account for recent transfusion or pregnancy history within the last three months.
Note special requirements (e.g., for antibody investigation, urgent transfusion).
Verification of Patient Information and History
Accurate patient identification is crucial for safe transfusions.
Patient history influences the interpretation of lab results.
Verification of patient records can identify:
Previous transfusions
Pregnancy history
Known antibodies
Previous ABO/Rh group results.
This information guides blood selection by influencing:
Identification of clinically significant antibodies
Special requirements like antigen-negative units or irradiated blood
History of transfusion reactions.
Failure to verify patient history can lead to hemolytic transfusion reactions (HTR).
Specimen Retention and Management
Specimens retained based on:
Test type
Clinical significance
Regulatory and institutional policies.
Storage Conditions:
Refrigerators (2–8 °C):
For short-term storage of blood specimens and components.
Freezers (–20 °C or –80 °C):
For long-term storage of plasma, serum, or reference samples.
Continuous temperature monitoring required (24/7).
Dry Ice:
Used for frozen specimens like frozen plasma.
Must use insulated containers with proper ventilation.
Liquid Nitrogen:
Utilized for long-term cryopreservation of rare RBCs and cord blood stem cells.
Essential for preserving frozen RBCs with unusual antigenic profiles to assist in antibody identification.
Disposal of Specimens:
Specimens must be treated as biomedical waste.
Decontamination processes, e.g., autoclaving, applied as needed.
Disposal managed by approved biohazard waste contractors.
Disposal procedures documented to maintain traceability and compliance.
Summary of Retention and Record Keeping
Specimens: Retained as per policy (often for 7 – 14 days post-transfusion or longer).
Blood Bank Records: Retained for 10 – 30 years, subject to regulations.
Transfusion Records: Documentation of blood product release, including:
Recipient ID
Donation codes
Product lot numbers must be preserved for at least 50 years.
Current Good Manufacturing Practice (CGMP)
CGMP principles require that all recorded data be:
Accurate
Complete
Legible
Traceable
Data errors must be corrected without erasing or deleting the original entry:
Original entry must remain legible with corrections clearly identified.
Each correction must state the reason for the change, date, and identity (initials/signature) of the person making the correction.
Corrections must adhere to approved Standard Operating Procedures (SOPs) and may require supervisory review for critical records.